Evidence map›Paper›PMID 36617628›Full record

ArticleGut microbes

Human milk oligosaccharides, antimicrobial drugs, and the gut microbiota of term neonates: observations from the KOALA birth cohort study.

D J M Barnett, M F Endika, C E Klostermann, F Gu, C Thijs, A Nauta, H A Schols, H Smidt, I C W Arts, J Penders

Erratum issuedAbstract read
In one paragraph

Article in Gut microbes. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Understanding the influence of the microbiome on childhood infections.Expert review of anti-infective therapy · 2024
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

D J M BarnettMaastricht Centre for Systems Biology (MaCSBio), Maastricht University, Maastricht, The Netherlands.ORCID 0000-0003-1961-7206
M F EndikaLaboratory of Microbiology, Wageningen University & Research, Wageningen, The Netherlands.ORCID 0000-0003-1548-2404
C E KlostermannBiobased Chemistry and Technology, Wageningen University & Research, Wageningen, the Netherlands.
F GuLaboratory of Food Chemistry, Wageningen University & Research, Wageningen, The Netherlands.
C ThijsDepartment of Epidemiology, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0001-6646-5458
A NautaFrieslandCampina, LE Amersfoort, The Netherlands.
H A ScholsLaboratory of Food Chemistry, Wageningen University & Research, Wageningen, The Netherlands.
H SmidtLaboratory of Microbiology, Wageningen University & Research, Wageningen, The Netherlands.ORCID 0000-0002-6138-5026
I C W ArtsMaastricht Centre for Systems Biology (MaCSBio), Maastricht University, Maastricht, The Netherlands.ORCID 0000-0001-6462-6692
J PendersDepartment of Medical Microbiology, Maastricht University Medical Center, Maastricht, The Netherlands.ORCID 0000-0001-9146-5919

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The infant gut microbiota affects childhood health. This pioneer microbiota may be vulnerable to antibiotic exposures, but could be supported by prebiotic oligosaccharides found in breast milk and some infant formulas. We sought to characterize the effects of several exposures on the neonatal gut microbiota, including human milk oligosaccharides (HMOs), galacto-oligosaccharides (GOS), and infant/maternal antimicrobial exposures. We profiled the stool microbiota of 1023 one-month-old infants from the KOALA Birth Cohort using 16S rRNA gene amplicon sequencing. We quantified 15 HMOs in breast milk from the mothers of 220 infants, using high-performance liquid chromatography-mass spectrometry. Both breastfeeding and antibiotic exposure decreased gut microbial diversity, but each was associated with contrasting shifts in microbiota composition. Other factors associated with microbiota composition included C-section, homebirth, siblings, and exposure to animals. Neither infant exposure to oral antifungals nor maternal exposure to antibiotics during pregnancy were associated with infant microbiota composition. Four distinct groups of breast milk HMO compositions were evident, corresponding to maternal Secretor status and Lewis group combinations defined by the presence/absence of certain fucosylated HMOs. However, we found the strongest evidence for microbiota associations between two non-fucosylated HMOs: 6'-sialyllactose (6'-SL) and lacto-N-hexaose (LNH), which were associated with lower and higher relative abundances of

Indexed as

Anti-Infective AgentsGastrointestinal MicrobiomePhascolarctidaeAnimalsAnti-Bacterial AgentsBreast FeedingChildCohort StudiesFemaleHumansInfantInfant, NewbornMilk, HumanOligosaccharidesPrebioticsPregnancyAnti-Bacterial AgentsAnti-Infective AgentsOligosaccharidesPrebioticsRNA, Ribosomal, 16Santibioticsbreastfeedinggut microbiomehuman milk oligosaccharidesInfant nutritionprebiotics

Identifiers

PMID36617628
PMCPMC9833409

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.